{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T00:45:41Z","timestamp":1791333941855,"version":"4.3.1"},"reference-count":18,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Immunological Methods"],"published-print":{"date-parts":[[2022,10]]},"DOI":"10.1016\/j.jim.2022.113340","type":"journal-article","created":{"date-parts":[[2022,8,27]],"date-time":"2022-08-27T06:12:48Z","timestamp":1661580768000},"page":"113340","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Repeatability of QuantiFERON-TB gold plus testing utilizing microparticle chemiluminescence"],"prefix":"10.1016","volume":"509","author":[{"given":"Caleb","family":"Cornaby","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher K.","family":"Giardina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John L.","family":"Schmitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jim.2022.113340_bb0005","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1093\/jalm\/jfab012","article-title":"Performance of an advanced interferon-gamma release assay for mycobacterium tuberculosis detection","volume":"6","author":"Altawallbeh","year":"2021","journal-title":"J. Appl. Lab. Med."},{"key":"10.1016\/j.jim.2022.113340_bb0010","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.inhe.2009.09.001","article-title":"The international union against tuberculosis and lung disease: past, present and future","volume":"1","author":"Billo","year":"2009","journal-title":"Int. Health"},{"key":"10.1016\/j.jim.2022.113340_bb0015","doi-asserted-by":"crossref","DOI":"10.1128\/JCM.00780-20","article-title":"QuantiFERON-TB gold plus with chemiluminescence immunoassay: do we need a higher cutoff?","volume":"58","author":"Bisognin","year":"2020","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.jim.2022.113340_bb0020","doi-asserted-by":"crossref","DOI":"10.1128\/JCM.00272-20","article-title":"Accuracy of QuantiFERON-TB gold plus test for diagnosis of Mycobacterium tuberculosis infection in children","volume":"58","author":"Buonsenso","year":"2020","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.jim.2022.113340_bb0025","doi-asserted-by":"crossref","DOI":"10.1128\/JCM.00159-20","article-title":"Evaluation of QuantiFERON-TB gold plus on liaison XL in a low-tuberculosis-incidence setting","volume":"58","author":"De Maertelaere","year":"2020","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.jim.2022.113340_bb0030","doi-asserted-by":"crossref","DOI":"10.1128\/JCM.00603-21","article-title":"Evaluation of the fully automated chemiluminescence analyzer liaison XL for the performance of the QuantiFERON-TB gold plus assay in an area with a low incidence of tuberculosis","volume":"59","author":"Fern\u00e1ndez-Huerta","year":"2021","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.jim.2022.113340_bb0035","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.3201\/eid2410.180716","article-title":"Simple estimates for local prevalence of latent tuberculosis infection, United States, 2011\u20132015","volume":"24","author":"Haddad","year":"2018","journal-title":"Emerg. Infect. Dis."},{"key":"10.1016\/j.jim.2022.113340_bb0040","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1093\/ibd\/izaa139","article-title":"Approach to latent tuberculosis infection screening before biologic therapy in IBD patients: PPD or IGRA?","volume":"26","author":"Hashash","year":"2020","journal-title":"Inflamm. Bowel Dis."},{"key":"10.1016\/j.jim.2022.113340_bb0045","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1093\/clinids\/17.6.968","article-title":"The tuberculin skin test","volume":"17","author":"Huebner","year":"1993","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.jim.2022.113340_bb0050","doi-asserted-by":"crossref","first-page":"2389","DOI":"10.7754\/Clin.Lab.2020.200338","article-title":"Operational usability evaluation of the LIAISON\u00ae QuantiFERON\u00ae-TB gold plus solution in a high volume laboratory setting","volume":"66","author":"Kadkhoda","year":"2020","journal-title":"Clin. Lab."},{"key":"10.1016\/j.jim.2022.113340_bb0055","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1183\/09031936.00040007","article-title":"Clinical evaluation of QuantiFERON TB-2G test for immunocompromised patients","volume":"30","author":"Kobashi","year":"2007","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.jim.2022.113340_bb0060","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1128\/CDLI.6.4.606-609.1999","article-title":"Cellular immune responses to ESAT-6 discriminate between patients with pulmonary disease due to Mycobacterium avium complex and those with pulmonary disease due to Mycobacterium tuberculosis","volume":"6","author":"Lein","year":"1999","journal-title":"Clin. Diagn. Lab. Immunol."},{"key":"10.1016\/j.jim.2022.113340_bb0065","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0140881","article-title":"Tuberculosis infection in the United States: Prevalence estimates from the national health and nutrition examination survey, 2011-2012","volume":"10","author":"Miramontes","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.jim.2022.113340_bb0070","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1128\/JCM.02498-16","article-title":"Evaluation of QuantiFERON-TB gold-plus in health care workers in a low-incidence setting","volume":"55","author":"Moon","year":"2017","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.jim.2022.113340_bb0075","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1164\/rccm.200402-179OC","article-title":"Specific detection of tuberculosis infection: an interferon-\u03b3-based assay using new antigens","volume":"170","author":"Mori","year":"2004","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.jim.2022.113340_bb0080","series-title":"Tuberculosis and Nontuberculous Mycobacterial Infections","author":"Schlossberg","year":"2017"},{"key":"10.1016\/j.jim.2022.113340_bb0085","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1093\/aje\/kwt246","article-title":"Estimated rate of reactivation of latent tuberculosis infection in the United States, overall and by population subgroup","volume":"179","author":"Shea","year":"2014","journal-title":"Am. J. Epidemiol."},{"key":"10.1016\/j.jim.2022.113340_bb0090","series-title":"Module 1: Prevention. Tuberculosis preventive treatment, Tuberculosis, Lung Diseases, HIV Infection","first-page":"86","article-title":"WHO consolidated guidelines on tuberculosis","author":"W.H. Organizat","year":"2021"}],"container-title":["Journal of Immunological Methods"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022175922001272?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022175922001272?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,19]],"date-time":"2025-09-19T16:38:42Z","timestamp":1758299922000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022175922001272"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10]]},"references-count":18,"alternative-id":["S0022175922001272"],"URL":"https:\/\/doi.org\/10.1016\/j.jim.2022.113340","relation":{},"ISSN":["0022-1759"],"issn-type":[{"value":"0022-1759","type":"print"}],"subject":[],"published":{"date-parts":[[2022,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Repeatability of QuantiFERON-TB gold plus testing utilizing microparticle chemiluminescence","name":"articletitle","label":"Article Title"},{"value":"Journal of Immunological Methods","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jim.2022.113340","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"113340"}}